These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11759381)

  • 1. [The safety of new quinolone treatment--levoflaxacin (tavanic) and moxiflocacin (megaxin)-- in the community].
    Bolkovshtein M; Lederman N; Berkovitch M
    Harefuah; 2001 Nov; 140(11):1054-7. PubMed ID: 11759381
    [No Abstract]   [Full Text] [Related]  

  • 2. An updated safety profile of moxifloxacin.
    Iannini PB; Mandell LA
    J Chemother; 2002 Feb; 14 Suppl 2():29-34. PubMed ID: 12003138
    [No Abstract]   [Full Text] [Related]  

  • 3. Recurrent tendinitis after treatment with two different fluoroquinolones.
    Burkhardt O; Köhnlein T; Pap T; Welte T
    Scand J Infect Dis; 2004; 36(4):315-6. PubMed ID: 15198194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New antibiotics in primary care].
    Horcajada JP; Martínez JA
    Rev Esp Quimioter; 2003 Mar; 16(1):118-22. PubMed ID: 12760359
    [No Abstract]   [Full Text] [Related]  

  • 5. [Moxifloxacin--a novel antimicrobial preparation for treatment of respiratory infections].
    Iakovlev SV; Polushkina NR; Iakovlev VP
    Ter Arkh; 2001; 73(11):15-22. PubMed ID: 11806197
    [No Abstract]   [Full Text] [Related]  

  • 6. New generations of quinolones: with particular attention to levofloxacin.
    Ambrose PG; Owens RC; Quintiliani R; Nightingale CH
    Conn Med; 1997 May; 61(5):269-72. PubMed ID: 9197076
    [No Abstract]   [Full Text] [Related]  

  • 7. Levofloxacin and moxifloxacin increase human gut colonization by Candida species.
    Samonis G; Kofteridis DP; Maraki S; Alegakis D; Mantadakis E; Papadakis JA; Gikas AH; Falagas ME
    Antimicrob Agents Chemother; 2005 Dec; 49(12):5189. PubMed ID: 16304202
    [No Abstract]   [Full Text] [Related]  

  • 8. [Playing it safe in bronchopulmonary infections].
    MMW Fortschr Med; 2003 May; 145(18):57. PubMed ID: 12838909
    [No Abstract]   [Full Text] [Related]  

  • 9. [The safety profile and tolerance of levofloxacin].
    Honorato J; Caballero E; Campanero MA; Escolar M
    Enferm Infecc Microbiol Clin; 1999; 17 Suppl 1():44-6. PubMed ID: 10563111
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis: a randomized clinical trial.
    Constantinou M; Daniell M; Snibson GR; Vu HT; Taylor HR
    Ophthalmology; 2007 Sep; 114(9):1622-9. PubMed ID: 17822972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Do tendon lesions occur during quinolone administration?].
    Shah P
    Dtsch Med Wochenschr; 2003 Oct; 128(42):2214. PubMed ID: 14562223
    [No Abstract]   [Full Text] [Related]  

  • 12. Moxifloxacin: new preparation. A me-too with more cardiac risks.
    Prescrire Int; 2002 Dec; 11(62):168-9. PubMed ID: 12469694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic anaphylaxis caused by moxifloxacin.
    Sánchez-Morillas L; Rojas Pérez-Ezquerra P; Reaño-Martos M; Laguna-Martínez JJ; Gómez-Tembleque P
    Allergol Immunopathol (Madr); 2010; 38(4):226-7. PubMed ID: 20089346
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effectiveness of a new fluoroquinolone antibiotic avelox in the treatment of suppurative sinusitis].
    Egorov VI; Kozarenko AV
    Vestn Otorinolaringol; 2002; (5):35-6. PubMed ID: 12524963
    [No Abstract]   [Full Text] [Related]  

  • 15. Concurrent use of selected agents with moxifloxacin: an examination of labeling compliance within 1 year of marketing.
    Brinker A; Staffa J
    Arch Intern Med; 2002 Sep; 162(17):2011-2. PubMed ID: 12230426
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay.
    Schein J; Janagap-Benson C; Grant R; Sikirica V; Doshi D; Olson W
    Curr Med Res Opin; 2008 Mar; 24(3):895-906. PubMed ID: 18419876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Respiratory tract infections. Increasingly more established antibiotics fail].
    MMW Fortschr Med; 2002 Oct; 144(42):65. PubMed ID: 12534005
    [No Abstract]   [Full Text] [Related]  

  • 18. [Moxifloxacin].
    Caballero E; Cárdenas E; Gurucharri N; Rodrigo A; Honorato J
    Rev Med Univ Navarra; 2000; 44(4):53-60. PubMed ID: 11341057
    [No Abstract]   [Full Text] [Related]  

  • 19. Reassuring safety profile of moxifloxacin.
    Iannini PB; Kubin R; Reiter C; Tillotson G
    Clin Infect Dis; 2001 Apr; 32(7):1112-4. PubMed ID: 11264046
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapy study of acute exacerbated chronic bronchitis. Quinolone rapidly improves cough and chest pain. BRONCHIMOX Study Group].
    Lorenz J; Busch W; Thate-Waschke IM
    MMW Fortschr Med; 2000 Jun; 142(22):35. PubMed ID: 10870381
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.